Squareone Capital

Squareone Capital is an emerging Buenos Aires micro-VC focused on Argentine technical founders building SaaS and AI platforms, with checks under $250k at Pre-Seed and Seed. The fund’s positioning is local and technical, with relevant healthcare surfaces including AI applications, clinical software, telemedicine, and B2B platforms targeting Argentine and Spanish-speaking LatAm enterprise buyers. Founders pursuing biotech, MedTech with regulatory clearance pathways, or care delivery should look at later-stage LatAm capital or international funds. The right founder is an Argentine technical operator with a sharp wedge, comfortable with a fund that runs small concentrated tickets and is most useful as the first institutional check on a credible team. Argentina’s macro context shapes everything: peso volatility, capital controls, and a structurally small domestic enterprise market mean serious founders typically domicile in Delaware or a similar holding structure, hire technical talent in Argentina at strong dollar-equivalent margins, and target Mexico, Brazil, the US, and Spain as commercial markets. Squareone is fluent in this playbook and is most valuable when a founder is making those structural decisions early. Best entry is a warm intro from an Argentine founder in the ecosystem; the fund’s deal flow runs through trust networks rather than cold inbound. Lead the pitch with the technical team, the wedge, and a credible plan to land first revenue outside Argentina within twelve months. AI healthcare founders should describe data asset compounding, model evaluation, and any regulatory positioning under ANMAT or equivalent international regulators. Caveats are sized to the check and the macro. Sub-$250k cannot anchor a real Seed round, so founders need to syndicate with stronger LatAm or US Seed funds and plan dilution accordingly. Argentine peso exposure on the operating side is a real risk; ask Squareone how it has structured runway and treasury for portfolio companies through past devaluation cycles. Confirm the fund’s vintage, reserves, and follow-on policy, because emerging managers can run out of dry powder during follow-on rounds. Reference checks with portfolio founders on operating support and cross-border introductions to Mexican, Brazilian, and US Seed funds are worth the time. Used appropriately, Squareone is a credible early ticket for Argentine technical founders; used as the lead on a serious healthcare cap table, it is undersized for the operating risk involved.